The goal of this project is to examine the effect of naltrexone, an opioid antagonist, on voluntary alcohol consumption in nontreatment seeking alcohol dependent volunteers using a laboratory self-administration paradigm. The specifics are: 1) to determine whether subjects on naltrexone exhibit greater reductions in voluntary alcohol consumption than subjects on placebo; 2) to determine whether naltrexone modifies the subjective and neuroendocrine responses to alcohol; 3) to evaluate whether the subjective and neuroendocrine responses to alcohol predict further voluntary alcohol consumption; and 4) to determine whether naltrexone affects voluntary alcohol consumption and responses to alcohol differently for men and women and ; 5) to determine if naltrexone alters anxiety in response to a stressor. We have recruited 37 subjects so far, of which 32 subjects have successfully completed both laboratory sessions. In a preliminary analyses of the data from the first 21 subjects, naltrexone was found to suppress alcohol-induced release of ACTH and cortisol and increases in heart rate and blood pressure, but we did not find differences in the number of drinks chosen in the two lab sessions or in indices for """"""""craving"""""""". We felt that the strength of the current paradigm lies in the use of low doses of alcohol, the use of an alcohol dependent sample rather than social drinkers. However, this paradigm also has some limitations such as the lack of powerful alternative reinforcers and the need for an alternative """"""""craving"""""""" assessment scale which would balance brevity and reliability of assessments. Therefore we have modified the current paradigm and are piloting a new third laboratory session which provides subjects with the opportunity to either drink up to 8 drinks or chose to obtain the monetary value of each drink. This new protocol may be more sensitive to changes in number of drinks consumed and """"""""craving"""""""" for alcohol. Our overall plan has not changed substantially, We hope to recruit and complete running 25-30 subjects this year.

Project Start
1997-04-01
Project End
1997-11-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
34
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Kelsey, Megan M; Braffett, Barbara H; Geffner, Mitchell E et al. (2018) Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. J Clin Endocrinol Metab 103:2309-2318
Kleinberger, Jeffrey W; Copeland, Kenneth C; Gandica, Rachelle G et al. (2018) Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med 20:583-590
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
Kriska, Andrea; El Ghormli, Laure; Copeland, Kenneth C et al. (2018) Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes. Pediatr Diabetes 19:36-44
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Venditti, E M; Tan, K; Chang, N et al. (2018) Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes. Diabetes Res Clin Pract 139:24-31
Gidding, Samuel S; Bacha, Fida; Bjornstad, Petter et al. (2018) Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr 192:86-92.e5
Arslanian, Silva; El Ghormli, Laure; Bacha, Fida et al. (2017) Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care 40:85-93
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Krystal, John H (2016) Neuroethology as a translational neuroscience strategy in the era of the NIMH Research Domain Criteria. Psychophysiology 53:364-6

Showing the most recent 10 out of 343 publications